Overview
?
Ulrich Dauer
See more contacts
Scientific Research and Development Services
,
Pharmaceutical and Medicine Manufacturing
,
Business Support Services
,
Medical research
,
Proprietary drug products
See All Industries Business services, nec
See Fewer Industries
See All Industries Business services, nec
See Fewer Industries
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
Actual
$30
DEC
?
?
AEX Index:VVY
Contacts
Get in Touch with 3 Principals*
-
Ulrich DauerChief Executive Officer
-
Contact 2?
-
Contact 3?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2012 (12 month period) in USD
Annual Revenue 2023
$-4.60 million
USD
Actual
1 USD = 0.7867 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net Operating Cash | -$27 | -$28 | -$14 |
| Net Investing Cash | -$13 | -$0 | -$0 |
| Net Financing Cash | $31 | $42 | -$1 |
| Net Change in Cash | -$10 | $15 | -$15 |
| Cash at Beginning of Period | $34 | $19 | $33 |
| Cash at End of Period | $24 | $34 | $19 |
| Capital Expenditure | -$1 | -$0 | -$0 |
| Assets (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $24 | $34 | $19 |
| Accounts Receivable | $ | $ | $ |
| Inventories | $ | $ | $ |
| Other Current Assets | $14 | $5 | $7 |
| Asset Summary | |||
| Total Current Assets | $38 | $39 | $26 |
| Tangible Fixed Assets | $0 | $0 | $0 |
| Intangible Assets | $1 | $1 | $1 |
| Total Assets | $31 | $31 | $25 |
| Liabilities (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $4 | $3 | $6 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $0 | $1 | $1 |
| Liability Summary | |||
| Total Current Liabilities | $4 | $4 | $6 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $ | $1 |
| Total Liabilities | $6 | $6 | $10 |
| Stakeholder's Equity (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Equity | |||
| Common Stock | $33 | $31 | $25 |
| Retained Earnings | -$189 | -$153 | -$117 |
| Equity Summary | |||
| Total Equity | $33 | $34 | $21 |
| Shares Outstanding | 26,066,808 | 24,105,278 | 20,050,482 |